Overview

Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of irinotecan and capecitabine in Asian subjects with inoperable hepatocellular carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Camptothecin
Capecitabine
Irinotecan